Report Description
Bio Pharmaceuticals Market Outlook
Bio Pharmaceuticals Market Report is expected to grow at CAGR 14% by 2028. Bio Pharmaceuticals Market Report was $XX Million in 2020 and is expected to reach $XX Billion by the forecasted period 2021 to 2028. A biopharmaceutical, also known as a medical or biological product, is any pharmaceutical product that is manufactured, extracted or semi-synthesized from biological sources. Unlike fully synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergens, somatic cells, gene therapies, tissues, recombinant therapeutic proteins, and live drugs used in cell therapy. Biological products can be composed of sugars, proteins, nucleic acids or complex combinations of these substances, or perhaps living cells or tissues. They are isolated from living human, animal, plant, fungal or microbial sources. They can be used in human and animal medicine.Bio Pharmaceuticals Market Dynamic
The biopharmaceutical market is expected to grow at a rapid pace over the next five years, driven by the growing inclination towards targeted therapy and increasing investment in research and development. The treatment of various chronic diseases was risky and had negative side effects. For example, conventional chemotherapy was toxic and had significant side effects. The development of improved biopharmaceuticals has provided a safer alternative to these traditional therapies, and the growing awareness of the benefits of biopharmaceuticals over traditional therapies is expected to drive the market growth. Biopharmaceuticals due to the increase in chronic diseases and growing geriatric population are the most significant factor driving the growth of this market. Additionally, the ability of biopharmaceuticals to treat incurable conditions is also expected to accelerate the overall market growth. In addition, the expansion of the healthcare sector for a long time that the growing awareness of the efficacy and availability of biopharmaceuticals among the population is also expected to dampen the growth of the market over the course of the projected period. Increased efforts in the development of the biopharmaceutical industry are also expected to enhance the market growth. Investments to Generate Opportunities In addition, accelerating focus on research and related investments is expected to generate profitable opportunities for the market. Increasing investments by market players in the research and development of new drugs and their clinical trials, along with increasing government investments to develop the biopharmaceutical industry, will also provide ample growth opportunities for the market. The high costs of innovative biopharmaceuticals limit their adoption by people in low- and middle-income countries due to their low accessibility. In addition, the lack of adequate sanitation infrastructure results in under-treatment. This is a major factor that may hinder the growth of the global biopharmaceutical market during the forecast period.Bio Pharmaceuticals Market Scope
CSP research recently published a report titled "(Bio Pharmaceuticals Market)" on the strength of the industry conjointly the} current and future trends that play a key role within the growth of the business. The report also highlights the drivers and barriers to growth. The report provides in-depth research and business growth insights. It examines necessary factors resembling value and offers future growth opportunities and forecasts supported their industry analysis. Throughout the study, researchers also study company profiles with details of the large players in the market today. The market segments are On the basis of Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), On the basis of Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), On the basis of Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP / EP / JP) On the basis of Vendor Qualification Program Support), On the basis of Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other)Competitive Landscape
Global Bio Pharmaceuticals Market report landscape includes company profiles with detailed data such as business overview, deals and specifications, key monetary metrics (total, gross and net), COVID19 impact analysis, SWOT analysis, market share, production and capacity (MW), key development activities, etc. for market makers are Abbott Laboratories, AstraZeneca, Amgen Inc, Bayer AG, Bristol-Myers Squibb, Biogen, BioMarin Pharmaceutical Inc., bioM?rieux Lilly, Johnson & Johnson Private Limited, Sanofi, F. Hoffmann-La Roche Ltd, Roche Holding AG, Novartis International AG, Genentech Inc., Merck Serono, Invion Limited, ?lan Corporation, Novartis AG, Novo Nordisk A/S, Merck & Co., Inc, GlaxoSmithKline Plc, and Pfizer IncRegional Analysis
On the regional level presence, Bio Pharmaceuticals Market segmented into. North America, Europe, Latin America, Asia-Pacific including China and Middle East & Africa. This report is covered into geographically, with sales, revenue, market share and rate of growth Bio Pharmaceuticals Market in these regions. North America dominated the global biopharmaceutical market. Increased prevalence of various chronic diseases in the United States and growing geriatric population fueled the demand for biopharmaceuticals. Increasing investments by market players in research and development of new drugs and their clinical trials are expected to provide profitable growth opportunities for market players. Asia-Pacific is estimated to be the most opportunistic market during the forecast period. Countries like China, India, and South Korea are increasing their efforts to develop the biopharmaceutical industry and attract FDI due to the presence of low-cost inputs. The presence of some of the world's leading manufacturers and contract organizations in Asia Pacific has significantly boosted the growth of the biopharmaceutical market. Further increase in the prevalence of various chronic diseases and increase in the geriatric population in the region.Bio Pharmaceuticals Market Segments
On the basis of Product Type 1. Monoclonal Antibodies 2. Recombinant Growth Factors 3. Purified Proteins 4. Recombinant Proteins 5. Recombinant Hormone 6. Vaccines 7. Synthetic Immunomodulators 8. Other On the basis of Service 1. Laboratory Testing 2. Custom Testing / Customer Proprietary Testing 3. Compendial and Multi Compendial Laboratory Testing On the basis of Raw Material 1. Formulation Excipients 2. Active Pharmaceutical Ingredients (API) 3. Compendial Methods (USP / EP / JP) 4. Vendor Qualification Program Support On the basis of Application 1. Oncology 2. Inflammatory and Infectious Diseases 3. Autoimmune Disorders 4. Metabolic Disorders 5. Hormonal Disorders 6. Cardiovascular Diseases 7. Neurological Diseases 8. Other Major Players covered in the Report 1. Abbott Laboratories 2. AstraZeneca 3. Amgen Inc 4. Bayer AG 5. Bristol-Myers Squibb 6. Biogen 7. BioMarin Pharmaceutical Inc 8. BioM?rieux 9. Johnson & Johnson Private Limited 10. Sanofi 11. F. Hoffmann-La Roche Ltd 12. Roche Holding AG 13. Novartis International AG 14. Genentech Inc 15. Lilly 16. Merck Serono 17. Invion Limited 18. ?lan Corporation 19. Novo Nordisk A/S 20. Merck & Co., Inc 21. GlaxoSmithKline Plc 22. Pfizer Inc * Listed companies in this report may vary in the final report subject to Name Change / Merger etcGlobal Bio Pharmaceuticals Market: By Regional Analysis
1- North America A. U.S. B. Canada 2- Europe A. Germany B. U.K. C. France D. Italy E. Spain F. Rest of Europe 3- Asia Pacific A. China B. Japan C. India D. Rest of Asia Pacific 4- Latin America (LATAM) A. Brazil B. Mexico C. Rest of Latin America (LATAM) 5- Middle East & Africa (MEA) A. United Arab Emirates (UAE) B. Saudi Arabia C. Rest of Middle East & Africa (MEA) CSP Market Research analyst will gives you the thorough insightful information on Bio Pharmaceuticals Market Size, competitive landscape is delivered i.e. Revenue Share Analysis (MN USD) by top key Players, Revenue Market Share (%) by key Players and further a qualitative analysis is made headed for market cognizance rate, product differentiation, and new entrants are also considered in heat map concentration 1. Historical data- 2018 to 2019 2. The base year for estimation- 2020 3. Forecast period- 2021 to 2028Our Research Covers Competitors
1. Company Profile 2. Main Business Information 3. SWOT Analysis 4. Sales, Revenue, Price, and Gross Margin 5. Market ShareTarget Audience of the Bio Pharmaceuticals Market in this Study :
1. Key Consulting Companies & Advisors 2. Large, medium-sized, and small enterprises 3. Venture capitalists 4. Value-Added Resellers (VARs) 5. Third-party knowledge providers 6. Investment bankers 7. InvestorsKey Report Deliverables in the report Bio Pharmaceuticals Market
1- What is the market size and growth rate? 2- Inclusive details of factors that will challenge the growth of the market pre & post-COVID-19 with 4 types of market recovery scenarios including V shaped recovery, U shaped recovery, L shaped recovery, and W shaped recovery? 3- What are the factors anticipated to drive the global Bio Pharmaceuticals Market? 4- What are trends, restraints, and challenges in the global Bio Pharmaceuticals Market? 5- Segment-wise analysis of global Bio Pharmaceuticals Market? 6- Regional as well as country level analysis for Bio Pharmaceuticals Market? 7- Who are the potential customers of the global Bio Pharmaceuticals Market? 8- Analysis of major strategies by key market players? 9- How are collaborations evolving in the market? 10- How is the competitive environment? 11- Which region has attractive investment proposition? 12- Competitive Landscape with numerous analysis including revenue analysis, geographic presence analysis, competitive benchmarking, company evaluation matrix, competitive landscape, market positioning analysis, key strategies analysis, and others?Table of Content- Some Point Covered in the Report
Are you looking for a detailed TOC then speak with our analyst and fill the inquiry form. Chapter- 1. Research Framework keyword (Research Objective, Market Segmentation). Chapter- 2. Research Methodology- Qualitative Research, Primary & Secondary Sources, Quantitative Research, Primary & Secondary Sources, Market Size Estimation, Data Triangulation Chapter- 3. Executive Summary (Overview) Chapter- 4. Market Dynamics- Global Industry Outlook, Porter's Five Forces Model, COVID-19 Impact Assessment on Market, Major Strategies Adopted by Key Players, Market Positioning of Key Players Chapter- 5. Global keyword Analysis, by Market Segmentation- Key Insights, Market Size, and Forecast Chapter- 6. Global keyword Analysis, by Geography- Key Insights, Market Size, and Forecast (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). Chapter- 7. North America keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 8. Europe keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 9. Asia Pacific keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 10. Latin America keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 11. Middle East & Africa keyword Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation). Chapter- 12. Company Profiles- (Company, Company Basic Information, Manufacturing Base, Sales Area, Company Sales, and Net Income Highlights, Business Overview, Company News.Thanks for reading the article. We can also customize the report consistent with your requirements.
Geographical Analysis- Global Market Regional Analysis
What is the Report key Matric point?
|
Report Metric |
Details |
|
Market Study Available for Years |
2017–2030 Customize as per Requirement |
|
Base year Considered |
2020 Customize as per Requirement |
|
Historical Period |
2017- 2019 |
|
Forecast Period |
2021–2030 Customize as per Requirement |
|
Forecast Units |
Value (USD Million, Billion) As per Market |
|
Segments Covered |
Type, Application, and
Region- Customize as per Requirement |
|
Geographies Covered |
North America, Europe, Asia Pacific, Latin America, Middle East Africa and RoW- Customize as per Requirement |
Key Segments
Bio Pharmaceuticals Market Segments
On the basis of Product Type 1. Monoclonal Antibodies 2. Recombinant Growth Factors 3. Purified Proteins 4. Recombinant Proteins 5. Recombinant Hormone 6. Vaccines 7. Synthetic Immunomodulators 8. Other On the basis of Service 1. Laboratory Testing 2. Custom Testing / Customer Proprietary Testing 3. Compendial and Multi Compendial Laboratory Testing On the basis of Raw Material 1. Formulation Excipients 2. Active Pharmaceutical Ingredients (API) 3. Compendial Methods (USP / EP / JP) 4. Vendor Qualification Program Support On the basis of Application 1. Oncology 2. Inflammatory and Infectious Diseases 3. Autoimmune Disorders 4. Metabolic Disorders 5. Hormonal Disorders 6. Cardiovascular Diseases 7. Neurological Diseases 8. OtherMarket Segments Covered in the Report (Additional can be Customized)
Table of Content
Table of Content- Bio Pharmaceuticals Market
1. Introduction 1.1. Objective of the Study 1.2. Market Definition 1.3. Scope of the Study 1.3.1. Market Segmentation 1.3.1.1. Bio Pharmaceuticals Market , By Type 1.3.1.2. Bio Pharmaceuticals Market , By Service 1.3.1.3. Bio Pharmaceuticals Market , By Raw Material 1.3.1.4. Bio Pharmaceuticals Market , By Application 1.3.1.5. Bio Pharmaceuticals Market , By Geography 1.4. Currency Used 1.5. Years Considered for the Study 1.5.1. Historical Years 1.5.2. Base Year 1.5.3. Forecast Years 1.6. Limitations 1.7. Stakeholders 2. Executive Summary 2.1. Market Snapshot: Global Bio Pharmaceuticals Market 2.1.1. Interconnectivity and Related Markets 2.2. Key Insights 2.3. DROC (Drivers, Restraints, Opportunities, and Challenges) Analysis 2.4. Demand Side Trends 2.5. Supply Side Trends 2.6. Strategic Overview for Global Bio Pharmaceuticals Market 2.7. Voice of Industry Experts/Key Opinion Leaders (KOLs) 2.8. Recommendations and Conclusions 3. Research Methodology 3.1. Research Data 3.2. Market Breakdown and Data Triangulation 3.2.1. Secondary Research 3.2.2. Primary Research 3.2.3. Internal Repository Knowledge 3.3. Market Sizing Approach 3.3.1. 3600 View 3.3.2. Bottom Up Approach 3.3.3. Top Down Approach 3.4. Data Sources 3.4.1. Secondary Sources 3.4.2. Primary Sources 3.5. Name of Sources and References 4. COVID-19 Impact 4.1. COVID-19 Prevalence Analysis* 4.2. COVID-19 Vaccine Analysis* 4.3. COVID-19 Impact on Global Bio Pharmaceuticals Market 4.4. Pre vs Post COVID Demand and Supply Analysis 4.5. COVID-19 Road to Recovery Analysis 4.5.1. Global Bio Pharmaceuticals Market V Shaped Recovery 4.5.2. Global Bio Pharmaceuticals Market U Shaped Recovery 4.5.3. Global Bio Pharmaceuticals Market L Shaped Recovery 4.5.4. Global Bio Pharmaceuticals Market W Shaped Recovery 4.6. COVID-19 impact on End-user Industry 4.7. COVID-19 Opportunity Analysis 5. Prominent Insights 5.1. Macro-Economic Factors 5.1.1. Regional GDP Outlook 5.1.2. Key Industry News 5.1.3. Global Market Trend 5.1.3.1. Positive Trends 5.1.3.2. Negative Trends 5.1.4. Mechanism Integration 5.2. Ecosystem Mapping and Opportunity Analysis 5.3. Developed Vs Developing Economies 5.4. Market Dynamics 5.4.1. Market Drivers 5.4.1.1. Driver 1 5.4.1.2. Driver 2 5.4.1.3. Driver 3 5.4.1.4. Global Bio Pharmaceuticals Market Drivers Impact Assessment in the short, medium, and long terms 5.4.1.5. Global Bio Pharmaceuticals Market Drivers Impact Assessment at Regional Level 5.4.2. Market Restraints 5.4.2.1. Restraint 1 5.4.2.2. Restraint 2 5.4.2.3. Restraint 3 5.4.2.4. Global Bio Pharmaceuticals Market Restraints Impact Assessment in the short, medium, and long terms 5.4.2.5. Global Bio Pharmaceuticals Market Restraints Impact Assessment at Regional Level 5.4.3. Market Opportunities 5.4.3.1. Opportunity 1 5.4.3.2. Opportunity 2 5.4.3.3. Opportunity 3 5.4.3.4. Global Bio Pharmaceuticals Market Opportunities Impact Assessment in the short, medium, and long terms 5.4.3.5. Global Bio Pharmaceuticals Market Opportunities Impact Assessment at Regional Level 5.4.4. Market Challenges 5.4.4.1. Challenge 1 5.4.4.2. Challenge 2 5.4.4.3. Challenge 3 5.4.4.4. Global Bio Pharmaceuticals Market Challenges Impact Assessment in the short, medium, and long terms 5.4.4.5. Global Bio Pharmaceuticals Market Challenges Impact Assessment at Regional Level 5.5. Porter?s Five Forces Analysis 5.5.1. Threat Of New Entrants 5.5.2. Threat Of Substitutes 5.5.3. Bargaining Power Of Suppliers 5.5.4. Bargaining Power Of Buyers 5.5.5. Rivalry Among Existing Competitors 5.6. Value Chain Analysis 5.7. Attractive Investment Proposition, By Geography 5.8. Investment Landscape 5.8.1. Market Major Mergers & Acquisitions 5.8.2. Market Fund Raise and Other Activities 6. Global Bio Pharmaceuticals Market Analysis and Forecast, By Type, 2017-2028 (US$ Mn) 6.1. Overview 6.1.1. Global Bio Pharmaceuticals Market , By Type, Market Share Comparison 2020 vs 2028 (%) 6.2. Monoclonal Antibodies 6.2.1. Global Bio Pharmaceuticals Market , By Monoclonal Antibodies, Analysis and Forecast, 2017-2028 (US$ Mn) 6.2.2. Global Bio Pharmaceuticals Market , By Monoclonal Antibodies, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.3. Recombinant Growth Factors 6.3.1. Global Bio Pharmaceuticals Market , By Recombinant Growth Factors, Analysis and Forecast, 2017-2028 (US$ Mn) 6.3.2. Global Bio Pharmaceuticals Market , By Recombinant Growth Factors, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.4. Purified Proteins 6.4.1. Global Bio Pharmaceuticals Market , By Purified Proteins, Analysis and Forecast, 2017-2028 (US$ Mn) 6.4.2. Global Bio Pharmaceuticals Market , By Purified Proteins, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.5. Recombinant Proteins 6.5.1. Global Bio Pharmaceuticals Market , By Recombinant Proteins, Analysis and Forecast, 2017-2028 (US$ Mn) 6.5.2. Global Bio Pharmaceuticals Market , By Recombinant Proteins, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.6. Recombinant Hormone 6.6.1. Global Bio Pharmaceuticals Market , By Recombinant Hormone, Analysis and Forecast, 2017-2028 (US$ Mn) 6.6.2. Global Bio Pharmaceuticals Market , By Recombinant Hormone, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.7. Vaccines 6.7.1. Global Bio Pharmaceuticals Market , By Vaccines, Analysis and Forecast, 2017-2028 (US$ Mn) 6.7.2. Global Bio Pharmaceuticals Market , By Vaccines, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.8. Synthetic Immunomodulators 6.8.1. Global Bio Pharmaceuticals Market , By Synthetic Immunomodulators, Analysis and Forecast, 2017-2028 (US$ Mn) 6.8.2. Global Bio Pharmaceuticals Market , By Synthetic Immunomodulators, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 6.9. Other 6.9.1. Global Bio Pharmaceuticals Market , By Other, Analysis and Forecast, 2017-2028 (US$ Mn) 6.9.2. Global Bio Pharmaceuticals Market , By Other, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 7. Global Bio Pharmaceuticals Market Analysis and Forecast, By Service, 2017-2028 (US$ Mn) 7.1. Overview 7.1.1. Global Bio Pharmaceuticals Market , By Service, Market Share Comparison 2020 vs 2028 (%) 7.2. Laboratory Testing 7.2.1. Global Bio Pharmaceuticals Market , By Laboratory Testing, Analysis and Forecast, 2017-2028 (US$ Mn) 7.2.2. Global Bio Pharmaceuticals Market , By Laboratory Testing, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 7.3. Custom Testing / Customer Proprietary Testing 7.3.1. Global Bio Pharmaceuticals Market , By Custom Testing / Customer Proprietary Testing, Analysis and Forecast, 2017-2028 (US$ Mn) 7.3.2. Global Bio Pharmaceuticals Market , By Custom Testing / Customer Proprietary Testing, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 7.4. Compendial and Multi Compendial Laboratory Testing 7.4.1. Global Bio Pharmaceuticals Market , By Compendial and Multi Compendial Laboratory Testing, Analysis and Forecast, 2017-2028 (US$ Mn) 7.4.2. Global Bio Pharmaceuticals Market , By Compendial and Multi Compendial Laboratory Testing, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8. Global Bio Pharmaceuticals Market Analysis and Forecast, By Raw Material, 2017-2028 (US$ Mn) 8.1. Overview 8.1.1. Global Bio Pharmaceuticals Market , By Raw Material, Market Share Comparison 2020 vs 2028 (%) 8.2. Formulation Excipients 8.2.1. Global Bio Pharmaceuticals Market , By Formulation Excipients, Analysis and Forecast, 2017-2028 (US$ Mn) 8.2.2. Global Bio Pharmaceuticals Market , By Formulation Excipients, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8.3. Active Pharmaceutical Ingredients (API) 8.3.1. Global Bio Pharmaceuticals Market , By Active Pharmaceutical Ingredients (API), Analysis and Forecast, 2017-2028 (US$ Mn) 8.3.2. Global Bio Pharmaceuticals Market , By Active Pharmaceutical Ingredients (API), Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8.4. Compendial Methods (USP / EP / JP) 8.4.1. Global Bio Pharmaceuticals Market , By Compendial Methods (USP / EP / JP), Analysis and Forecast, 2017-2028 (US$ Mn) 8.4.2. Global Bio Pharmaceuticals Market , By Compendial Methods (USP / EP / JP), Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 8.5. Vendor Qualification Program Support 8.5.1. Global Bio Pharmaceuticals Market , By Vendor Qualification Program Support, Analysis and Forecast, 2017-2028 (US$ Mn) 8.5.2. Global Bio Pharmaceuticals Market , By Vendor Qualification Program Support, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9. Global Bio Pharmaceuticals Market Analysis and Forecast, By Application, 2017-2028 (US$ Mn) 9.1. Overview 9.1.1. Global Bio Pharmaceuticals Market , By Application, Market Share Comparison 2020 vs 2028 (%) 9.2. Oncology 9.2.1. Global Bio Pharmaceuticals Market , By Oncology, Analysis and Forecast, 2017-2028 (US$ Mn) 9.2.2. Global Bio Pharmaceuticals Market , By Oncology, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.3. Inflammatory and Infectious Diseases 9.3.1. Global Bio Pharmaceuticals Market , By Inflammatory and Infectious Diseases, Analysis and Forecast, 2017-2028 (US$ Mn) 9.3.2. Global Bio Pharmaceuticals Market , By Inflammatory and Infectious Diseases, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.4. Autoimmune Disorders 9.4.1. Global Bio Pharmaceuticals Market , By Autoimmune Disorders, Analysis and Forecast, 2017-2028 (US$ Mn) 9.4.2. Global Bio Pharmaceuticals Market , By Autoimmune Disorders, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.5. Metabolic Disorders 9.5.1. Global Bio Pharmaceuticals Market , By Metabolic Disorders, Analysis and Forecast, 2017-2028 (US$ Mn) 9.5.2. Global Bio Pharmaceuticals Market , By Metabolic Disorders, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.6. Hormonal Disorders 9.6.1. Global Bio Pharmaceuticals Market , By Hormonal Disorders, Analysis and Forecast, 2017-2028 (US$ Mn) 9.6.2. Global Bio Pharmaceuticals Market , By Hormonal Disorders, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.7. Cardiovascular Diseases 9.7.1. Global Bio Pharmaceuticals Market , By Cardiovascular Diseases, Analysis and Forecast, 2017-2028 (US$ Mn) 9.7.2. Global Bio Pharmaceuticals Market , By Cardiovascular Diseases, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.8. Neurological Diseases 9.8.1. Global Bio Pharmaceuticals Market , By Neurological Diseases, Analysis and Forecast, 2017-2028 (US$ Mn) 9.8.2. Global Bio Pharmaceuticals Market , By Neurological Diseases, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 9.9. Other 9.9.1. Global Bio Pharmaceuticals Market , By Other, Analysis and Forecast, 2017-2028 (US$ Mn) 9.9.2. Global Bio Pharmaceuticals Market , By Other, Analysis and Forecast, By Region, 2017-2028 (US$ Mn) 10. Global Bio Pharmaceuticals Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 10.1. Overview 10.2. Global Bio Pharmaceuticals Market , By Region, Market Share Comparison 2020 vs 2028 (%) 10.3. Global Bio Pharmaceuticals Market , By Region, Analysis and Forecast, 2017-2028 (US$ Mn) 10.4. Global Bio Pharmaceuticals Market , Regional Life Cycle Analysis 10.5. COVID-19 Impact on Global Bio Pharmaceuticals Market , By Region 11. North America Bio Pharmaceuticals Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 11.1. North America Bio Pharmaceuticals Market Overview 11.2. North America Bio Pharmaceuticals Market Summary 11.2.1. Dynamics 11.2.2. Impact Analysis 11.3. North America Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 11.4. North America Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 11.5. North America Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 11.6. North America Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 11.7. North America Bio Pharmaceuticals Market , By Country, 2017-2028 (US$ Mn) 11.7.1. U.S. 11.7.1.1. Overview 11.7.1.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 11.7.1.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 11.7.1.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 11.7.1.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 11.7.2. Canada 11.7.2.1. Overview 11.7.2.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 11.7.2.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 11.7.2.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 11.7.2.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12. Europe Bio Pharmaceuticals Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 12.1. Europe Bio Pharmaceuticals Market Overview 12.2. Europe Bio Pharmaceuticals Market Summary 12.2.1. Dynamics 12.2.2. Impact Analysis 12.3. Europe Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.4. Europe Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.5. Europe Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.6. Europe Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12.7. Europe Bio Pharmaceuticals Market , By Country, 2017-2028 (US$ Mn) 12.7.1. Germany 12.7.1.1. Overview 12.7.1.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.7.1.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.7.1.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.7.1.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12.7.2. U.K. 12.7.2.1. Overview 12.7.2.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.7.2.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.7.2.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.7.2.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12.7.3. France 12.7.3.1. Overview 12.7.3.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.7.3.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.7.3.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.7.3.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12.7.4. Italy 12.7.4.1. Overview 12.7.4.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.7.4.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.7.4.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.7.4.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12.7.5. Spain 12.7.5.1. Overview 12.7.5.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.7.5.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.7.5.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.7.5.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 12.7.6. Rest of Europe 12.7.6.1. Overview 12.7.6.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 12.7.6.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 12.7.6.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 12.7.6.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 13. Asia Pacific Bio Pharmaceuticals Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 13.1. Asia Pacific Bio Pharmaceuticals Market Overview 13.2. Asia Pacific Bio Pharmaceuticals Market Summary 13.2.1. Dynamics 13.2.2. Impact Analysis 13.3. Asia Pacific Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 13.4. Asia Pacific Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 13.5. Asia Pacific Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 13.6. Asia Pacific Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 13.7. Asia Pacific Bio Pharmaceuticals Market , By Country, 2017-2028 (US$ Mn) 13.7.1. China 13.7.1.1. Overview 13.7.1.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 13.7.1.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 13.7.1.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 13.7.1.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 13.7.2. Japan 13.7.2.1. Overview 13.7.2.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 13.7.2.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 13.7.2.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 13.7.2.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 13.7.3. India 13.7.3.1. Overview 13.7.3.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 13.7.3.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 13.7.3.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 13.7.3.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 13.7.4. Rest of Asia Pacific 13.7.4.1. Overview 13.7.4.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 13.7.4.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 13.7.4.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 13.7.4.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 14. Latin America (LATAM) Bio Pharmaceuticals Market Analysis and Forecast, By Regional Market Analysis, 2017-2028 (US$ Mn) 14.1. Latin America (LATAM) Bio Pharmaceuticals Market Overview 14.2. Latin America (LATAM) Bio Pharmaceuticals Market Summary 14.2.1. Dynamics 14.2.2. Impact Analysis 14.3. Latin America Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 14.4. Latin America Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 14.5. Latin America Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 14.6. Latin America Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 14.7. Latin America (LATAM) Bio Pharmaceuticals Market , By Country, 2017-2028 (US$ Mn) 14.7.1. Brazil 14.7.1.1. Overview 14.7.1.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 14.7.1.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 14.7.1.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 14.7.1.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 14.7.2. Mexico 14.7.2.1. Overview 14.7.2.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 14.7.2.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 14.7.2.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 14.7.2.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 14.7.3. Rest of Latin America (LATAM) 14.7.3.1. Overview 14.7.3.2. Bio Pharmaceuticals Market , By Type, 2017-2028 (US$ Mn) 14.7.3.3. Bio Pharmaceuticals Market , By Service, 2017-2028 (US$ Mn) 14.7.3.4. Bio Pharmaceuticals Market , By Raw Material, 2017-2028 (US$ Mn) 14.7.3.5. Bio Pharmaceuticals Market , By Application, 2017-2028 (US$ Mn) 15. Middle East & Africa (MEA) Bio Pharmaceuticals Market
Key Players
Major Players covered in the Report 1. Abbott Laboratories 2. AstraZeneca 3. Amgen Inc 4. Bayer AG 5. Bristol-Myers Squibb 6. Biogen 7. BioMarin Pharmaceutical Inc 8. BioM?rieux 9. Johnson & Johnson Private Limited 10. Sanofi 11. F. Hoffmann-La Roche Ltd 12. Roche Holding AG 13. Novartis International AG 14. Genentech Inc 15. Lilly 16. Merck Serono 17. Invion Limited 18. ?lan Corporation 19. Novo Nordisk A/S 20. Merck & Co., Inc 21. GlaxoSmithKline Plc 22. Pfizer Inc * Listed companies in this report may vary in the final report subject to Name Change / Merger etc
